EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Progressive conduction system disease preceding hypertrophy in IVS4+919G>A Fabry variant: a population-based electrocardiographic study

Wei-Hsin Chung iD, Cheng-Chang Tung iD, Ting-Yuan Liu, Wan-Jung Chang, Kuan-Cheng Chang iD, Wei-De Lin, Hsin-Yueh Liang iD, Fuu-Jen Tsai iD

Europace · 2026

DOI: 10.1093/europace/euag258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2026. Verfasst von Wei-Hsin Chung und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Taichung Municipal Geriatric Rehabilitation General Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Fabry Disease, Electrocardiography, Hypertrophy, Left Ventricular, alpha-Galactosidase. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The IVS4+919G>A variant is the most prevalent late-onset Fabry variant in East Asian populations, but its electrophysiological trajectory remains incompletely defined. Methods and results From a regional genetic screening programme, 905 IVS4+919G>A carriers were identified among 457 581 patients and matched 1:2 to controls by age and sex. Electrocardiographic (ECG) parameters were compared across decades, and echocardiography correlated structural changes with ECG findings. The cumulative prevalence of IVS4+919G>A was 0.198%. Age-specific prevalence in females was ∼2.5-fold higher than in males (0.11–0.15%), without significant change throughout different age categories. Female carriers demonstrated the catch-up phenomenon after the age of 60. Males exhibited a nine-fold risk of right bundle branch block and pacemaker implantation compared with male controls (right bundle branch block, HR 9.286, 95% CI 5.16–16.70, P < 0.001; pacemaker implantation, HR 9.197, 95% CI 2.88–29.31, P < 0.001), and this precedes the onset of echocardiographic left ventricular hypertrophy. Risk of stroke and atrial fibrillation (HR 1.435, 95% CI 0.69–2.96, P = 0.289) was similar between male carriers and controls. PR interval did not shorten but was prolonged instead. Combining left ventricular hypertrophy with conduction abnormalities, ECG detection achieved 88% sensitivity, exceeding echocardiographic criteria alone (51.5%).

Conclusion

The IVS4+919G>A variant is characterized by a progressive electrical phenotype dominated by conduction system disease preceding hypertrophy without excess major arrhythmic events. Electrocardiographic surveillance and phenotype-based risk stratification may be more informative than structural assessment alone for identifying individuals at risk of device therapy. Institutional Review Board: CMUH113-REC3-076

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fabry DiseaseElectrocardiographyHypertrophy, Left Ventricularalpha-GalactosidaseBundle-Branch BlockHeart Conduction SystemHumansMaleFemaleMiddle AgedDisease ProgressionPhenotypePrevalenceRisk FactorsGenetic Predisposition to DiseaseAgedAdultEchocardiographyCase-Control Studies

Stichwörter der Autor:innen

Cardiac Fabry’s diseaseElectrocardiographyRight bundle branch block

Substanzen

alpha-Galactosidase

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Taichung Municipal Geriatric Rehabilitation General Hospital, Taichung, Taiwan.
  • Division of Cardiology, Department of Medicine, China Medical University Hospital, Taichung, Taiwan.
  • Metal Industries Research and Development Centre, Kaohsiung, Taiwan.
  • Million-person Precision Medicine Initiative, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
  • Master Program for Digital Health Innovation, China Medical University, Taichung, Taiwan.
  • Department of Medical Research, China Medical University Hospital, Taichung 404332, Taiwan.

ORCID-Profile: Wei-Hsin Chung, Cheng-Chang Tung, Kuan-Cheng Chang, Hsin-Yueh Liang, Fuu-Jen Tsai

Zitieren

APA

Chung, W. H., Tung, C. C., Liu, T. Y., Chang, W. J., Chang, K. C., Lin, W. D., Liang, H. Y., & Tsai, F. J. (2026). Progressive conduction system disease preceding hypertrophy in IVS4+919G>A Fabry variant: a population-based electrocardiographic study. Europace. https://doi.org/10.1093/europace/euag258

Vancouver

Chung WH, Tung CC, Liu TY, Chang WJ, Chang KC, Lin WD, et al. Progressive conduction system disease preceding hypertrophy in IVS4+919G>A Fabry variant: a population-based electrocardiographic study. Europace. 2026. doi:10.1093/europace/euag258

BibTeX
@article{Chung2026,
  author = {Chung, Wei-Hsin and Tung, Cheng-Chang and Liu, Ting-Yuan and Chang, Wan-Jung and Chang, Kuan-Cheng and Lin, Wei-De and Liang, Hsin-Yueh and Tsai, Fuu-Jen},
  title = {Progressive conduction system disease preceding hypertrophy in IVS4+919G>A Fabry variant: a population-based electrocardiographic study},
  journal = {Europace},
  year = {2026},
  doi = {10.1093/europace/euag258}
}
Kostenlos starten →